DOI: https://doi.org/10.21203/rs.3.rs-78698/v1
Purpose: To evaluate the clinical value of robot-assisted perineal radical prostatectomy (RPRP) in the treatment of early localized prostate cancer.
Methods: We retrospectively analyzed 3 consecutive patients diagnosed with prostate cancer from January 2020 to May 2020 who received RPRP in our center. The main outcomes assessed were operating time, perioperative complications and need for conversion to open surgery.
Results: 3 patients successfully underwent RPRP with no conversion to open surgery. No intra-operative complications were seen. Average operative time was 201.67±61.53 min, console time was131.67±32.53 min, with an estimated blood loss of 183.33±28.87mL. 2 patients were discharged within 10 days postoperatively with perineal drainages removed. The Foley catheter was removed 2 weeks after surgery. One patient had a positive surgical margin (33.3%). 2 patients were continent immediately after removal of the Foley catheter, 1 patient was continent 1 month postoperatively. The sexual function of 2 patients recovered within 1 month and 1 patient recovered within 3 months. The PSA reexamination was 0-0.1µg/L one month after operation.
Conclusion: For patients with early localized prostate cancer, robot-assisted perineal radical prostatectomy is a safe and effective method, and has outstanding advantages in radical tumor resection and postoperative urine control.
This preprint is available for download as a PDF.